Results 121 to 130 of about 9,611,733 (341)
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit+19 more
wiley +1 more source
Integrative Family Therapy [PDF]
Reviewed Book: Olsen, David C. Integrative Family Therapy.
McCarl, Sandra A.
core +1 more source
Advances in cancer therapy: clinical benefit of new cancer drugs
Daniel Tobias Michaeli+2 more
openalex +1 more source
Respiratory Acidosis and Hypochloremic Alkalosis: Origins, Differentiation, Effects and Therapy [PDF]
T. S. Danowski
openalex +1 more source
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source
A CRITICAL STUDY OF REGIONAL INTRA-ARTERIAL NITROGEN MUSTARD THERAPY IN CANCER
Charles D. Bonner+2 more
openalex +2 more sources
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source